Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I clinical and pharmacokinetic trial of hepsulfam.
Ravdin PM, Havlin KA, Marshall MV, Brown TD, Koeller JM, Kuhn JG, Rodriguez G, Von Hoff DD. Ravdin PM, et al. Among authors: koeller jm. Cancer Res. 1991 Dec 1;51(23 Pt 1):6268-72. Cancer Res. 1991. PMID: 1933887 Clinical Trial.
A phase I trial of taxol given by a 6-hour intravenous infusion.
Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D. Brown T, et al. J Clin Oncol. 1991 Jul;9(7):1261-7. doi: 10.1200/JCO.1991.9.7.1261. J Clin Oncol. 1991. PMID: 1675263 Clinical Trial.
Phase I clinical and pharmacokinetic trial of flavone acetic acid.
Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller J, Harman G, Schwartz R, Clark GN, Von Hoff DD. Havlin KA, et al. J Natl Cancer Inst. 1991 Jan 16;83(2):124-8. doi: 10.1093/jnci/83.2.124. J Natl Cancer Inst. 1991. PMID: 1703237 Clinical Trial.
Local soft tissue toxicity following cisplatin extravasation.
Fields S, Koeller J, Topper RL, Guritz G, Von Hoff D. Fields S, et al. J Natl Cancer Inst. 1990 Oct 17;82(20):1649-50. doi: 10.1093/jnci/82.20.1649. J Natl Cancer Inst. 1990. PMID: 2145441 No abstract available.
New anticancer agents.
Brown TD, Havlin KA, Koeller JM, Kuhn JG, O'Rourke TJ, Rodriguez GI, Weiss GR, Von Hoff DD. Brown TD, et al. Among authors: koeller jm. Cancer Chemother Biol Response Modif. 1990;11:115-41. Cancer Chemother Biol Response Modif. 1990. PMID: 2223393 Review. No abstract available.
New anticancer agents.
Weiss GR, Arteaga CL, Brown TD, Craig JB, Harman GS, Havlin KA, Koeller JM, Kuhn JG, Von Hoff DD. Weiss GR, et al. Among authors: koeller jm. Cancer Chemother Biol Response Modif. 1988;10:85-116. Cancer Chemother Biol Response Modif. 1988. PMID: 2484323 Review. No abstract available.
New anticancer agents.
Weiss GR, Arteaga CL, Brown TD, Craig JB, Harman GS, Koeller JM, Kuhn JG, Von Hoff DD. Weiss GR, et al. Among authors: koeller jm. Cancer Chemother Biol Response Modif. 1987;9:93-120. Cancer Chemother Biol Response Modif. 1987. PMID: 2484330 Review. No abstract available.
Phase I clinical investigation of amonafide.
Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al. Saez R, et al. J Clin Oncol. 1989 Sep;7(9):1351-8. doi: 10.1200/JCO.1989.7.9.1351. J Clin Oncol. 1989. PMID: 2549205 Clinical Trial.
81 results